Fundraising Fox

Q Bio, Inc.

San Carlos, US · Delaware corporation · 3 known investors

q.bio

Q.bio provides quantitative biology assessments and longitudinal health monitoring for preventive care, offering comprehensive measurable exams at the scale of premium care providers.

AI & Machine LearningBiotechDigital HealthHealthtech

Founders & leadership

JK
Jeffrey KaditzFounder
CS
Clarissa ShenExecutive

Board

TD
Terry DoyleBoard director
VP
Vijay Pande, Ph.D.Board director

Investors · 3

Reported raises · per SEC filings

Form D private placements

$27.1M disclosed across 1 round · 2024

$27.1MraisedJul 2024 · 14 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Terry DoyleDirector
  • Vijay Pande, Ph.D.Director
  • Clarissa ShenExecutive Officer
  • Jeffrey KaditzExecutive Officer, Director, Promoter
Offering amount
$27.1M
Amount sold
$27.1M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Q Bio, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Q Bio, Inc. do?
Q.bio provides quantitative biology assessments and longitudinal health monitoring for preventive care, offering comprehensive measurable exams at the scale of premium care providers.
Who founded Q Bio, Inc.?
Q Bio, Inc. was founded by Jeffrey Kaditz.
Who are Q Bio, Inc.'s investors?
Q Bio, Inc.'s investors include Andreessen Horowitz, Beast Ventures, Evolution Ventures.
How much funding has Q Bio, Inc. raised?
Q Bio, Inc. has disclosed $27.1M raised across 1 round.
Where is Q Bio, Inc. headquartered?
Q Bio, Inc. is headquartered in San Carlos, US.